FR2284331A1 - Produits pharmaceutiques contenant un compose organo-silicie en tant qu'agent actif - Google Patents

Produits pharmaceutiques contenant un compose organo-silicie en tant qu'agent actif

Info

Publication number
FR2284331A1
FR2284331A1 FR7431435A FR7431435A FR2284331A1 FR 2284331 A1 FR2284331 A1 FR 2284331A1 FR 7431435 A FR7431435 A FR 7431435A FR 7431435 A FR7431435 A FR 7431435A FR 2284331 A1 FR2284331 A1 FR 2284331A1
Authority
FR
France
Prior art keywords
trimethylsilyl
para
treatment
troubles
medicaments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7431435A
Other languages
English (en)
Other versions
FR2284331B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cortial SA
Original Assignee
Cortial SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cortial SA filed Critical Cortial SA
Priority to FR7431435A priority Critical patent/FR2284331A1/fr
Priority to AR260327A priority patent/AR208203A1/es
Priority to BE158972A priority patent/BE832165A/fr
Priority to GB35280/75A priority patent/GB1508338A/en
Priority to DE19752538292 priority patent/DE2538292A1/de
Priority to NL7510317A priority patent/NL7510317A/xx
Priority to IL48052A priority patent/IL48052A0/xx
Priority to ZA00755661A priority patent/ZA755661B/xx
Priority to OA55605A priority patent/OA05105A/fr
Priority to LU73351A priority patent/LU73351A1/xx
Priority to US05/611,847 priority patent/US4000265A/en
Priority to ES440861A priority patent/ES440861A1/es
Priority to JP50109915A priority patent/JPS5238034A/ja
Publication of FR2284331A1 publication Critical patent/FR2284331A1/fr
Application granted granted Critical
Publication of FR2284331B1 publication Critical patent/FR2284331B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/695—Silicon compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0803—Compounds with Si-C or Si-Si linkages
    • C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR7431435A 1974-09-10 1974-09-10 Produits pharmaceutiques contenant un compose organo-silicie en tant qu'agent actif Granted FR2284331A1 (fr)

Priority Applications (13)

Application Number Priority Date Filing Date Title
FR7431435A FR2284331A1 (fr) 1974-09-10 1974-09-10 Produits pharmaceutiques contenant un compose organo-silicie en tant qu'agent actif
AR260327A AR208203A1 (es) 1974-09-10 1975-01-01 Proceso para la preparacion de acido p-trialquilsilil benzoico y derivados del mismo
BE158972A BE832165A (fr) 1974-09-10 1975-08-06 Produits pharmaceutiques contenant un compose organo-silicie en tant qu'agent actif
GB35280/75A GB1508338A (en) 1974-09-10 1975-08-27 Pharmaceutical compositions
DE19752538292 DE2538292A1 (de) 1974-09-10 1975-08-28 Organosiliziumverbindungen enthaltende pharmazeutische zusammensetzungen
NL7510317A NL7510317A (nl) 1974-09-10 1975-09-02 Werkwijze voor het bereiden van een farmaceutisch preparaat waarin als werkzaam bestanddeel een organo-siliciumverbinding is opgenomen, en het volgens deze werkwijze verkregen preparaat.
IL48052A IL48052A0 (en) 1974-09-10 1975-09-04 Pharmaceutical compositions comprising as active agent an organosilicon compound
ZA00755661A ZA755661B (en) 1974-09-10 1975-09-04 Pharmaceutical compositions containing organo-silicon compounds
OA55605A OA05105A (fr) 1974-09-10 1975-09-09 Procédé de fabrication de composés anti-athéromateux.
LU73351A LU73351A1 (fr) 1974-09-10 1975-09-09
US05/611,847 US4000265A (en) 1974-09-10 1975-09-10 Method for treating arteriosclerotic and cardiovascular disorders
ES440861A ES440861A1 (es) 1974-09-10 1975-09-10 Procedimiento de fabricacion de derivados organicos del si- licio de caracter antiateromatoso.
JP50109915A JPS5238034A (en) 1974-09-10 1975-09-10 Medicine containing organosilion compound as active agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7431435A FR2284331A1 (fr) 1974-09-10 1974-09-10 Produits pharmaceutiques contenant un compose organo-silicie en tant qu'agent actif

Publications (2)

Publication Number Publication Date
FR2284331A1 true FR2284331A1 (fr) 1976-04-09
FR2284331B1 FR2284331B1 (fr) 1978-07-21

Family

ID=9143172

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7431435A Granted FR2284331A1 (fr) 1974-09-10 1974-09-10 Produits pharmaceutiques contenant un compose organo-silicie en tant qu'agent actif

Country Status (3)

Country Link
BE (1) BE832165A (fr)
FR (1) FR2284331A1 (fr)
ZA (1) ZA755661B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0008130A1 (fr) * 1978-08-15 1980-02-20 Shin-Etsu Chemical Co., Ltd. Composés organosiliciques pour le traitement de l'hypertension et des tumeurs

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5945M (fr) * 1965-07-29 1968-04-08

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5945M (fr) * 1965-07-29 1968-04-08

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0008130A1 (fr) * 1978-08-15 1980-02-20 Shin-Etsu Chemical Co., Ltd. Composés organosiliciques pour le traitement de l'hypertension et des tumeurs

Also Published As

Publication number Publication date
FR2284331B1 (fr) 1978-07-21
BE832165A (fr) 1975-12-01
ZA755661B (en) 1976-08-25

Similar Documents

Publication Publication Date Title
HU173557B (hu) Sposob poluchenija 3-amino-indazol-karbonovojj kisloty i farmacevticheskikh kompozicijj soderzhahhikh ikh aktivnymi agentami
PH16474A (en) Clavulcanic acid,salts and esters thereof and pharmaceutical compositions containing same
IE40307L (en) Pharmaceutical composition
MY110110A (en) Pharmaceuticals in the treatment of gastrointestinal disorders, cardiovascular disorders and cns disorders
GR3021789T3 (en) 17-Aryl and 17-heterocyclyl-14beta-5alpha-androstane, androstene and androstadiene derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing same
ES8402560A1 (es) Procedimiento para la obtencion de nuevos derivados de omega-ciano-1,omega-difenil-aza-alcano.
EP0293751A3 (en) Taurohyodeoxycholic acid for the therapy of calculosis of the biliary tract and of biliary dyspepsia
HUT38255A (en) Process for preparing pharmaceutical compositions containing pyrimido-pyrimidines and o-acetyl-salicylic acid resp. pharmaceutically acceptable salts thereof
FR2308372A2 (fr) Produits pharmaceutiques contenant un compose organosilicie en tant qu'agent actif
GB1341794A (en) Medicament for the treatment of hepatic disorders
FR2284331A1 (fr) Produits pharmaceutiques contenant un compose organo-silicie en tant qu'agent actif
ES8707734A1 (es) Procedimiento para la obtencion de cefalosporinas
PT82202A (en) Process for the preparation of polyprenyl compounds
JPS5679622A (en) Antitumor pharmaceutical
CA999236A (en) Process for producing 4-hydroxymethyl-1-keto-1, 2-dlhydrophthalazine and acid salts thereof, and pharmaceutical composition containing the same
HU9401977D0 (en) Process for producing pharmaceutical compositions containing beta-naphtoquinone derivatives and salts thereof with epithalial proliferation fastening and no-synthetase inhibiting activity
ES8203086A1 (es) Un procedimiento para la produccion de n,n'-bis-(3-picolil) -4-metoxi-isoftalamida monohidratada
GB1250421A (fr)
ES481296A1 (es) Un procedimiento para la preparacion de esteres de deriva- dos del acido aminolo-piran-4-ona-2-carboxilico.
WO1987003590A1 (fr) Medicament pour le traitement des maladies du foie
GB1449043A (en) Treatment of asthma
JPS525755A (en) Process for preparation of 3-amino-4-homotwistane and its acid salts
GB1391405A (en) N-acylated glucosamines
CA989309A (en) Pharmaceutical composition for the treatment of acne containing fatty acid amides
ES385522A1 (es) Un metodo para producir un compuesto de azamorfinano.

Legal Events

Date Code Title Description
ST Notification of lapse